Treatment Strategy for Elderly Patients with Soft Tissue Sarcoma.

Area of Science:

• Oncology
• Geriatrics
• Surgical Oncology

Background:

• Soft tissue sarcoma (STS) is a rare cancer.
• Standard treatment for localized STS is surgical resection, while advanced STS may be treated with chemotherapy.
• Elderly patients with STS often receive less aggressive treatment, potentially compromising outcomes.

Purpose of the Study:

• To review the literature on soft tissue sarcoma (STS) treatment in elderly patients.
• To emphasize the importance of standard treatment protocols for this demographic.
• To highlight the need for careful risk assessment in older adults undergoing cancer treatment.

Main Methods:

• Literature review of studies concerning STS treatment in elderly populations.
• Analysis of treatment outcomes based on patient age and comorbidities.
• Evaluation of risk assessment tools for surgical and systemic therapies.

Main Results:

• Surgical resection outcomes in elderly patients are comparable to younger patients when selected using the American Society of Anesthesiologists Physical Status (ASA-PS).
• Systemic treatment can be beneficial in elderly patients if risks are assessed through geriatric assessment (GA).
• Standard treatment for STS in the elderly is effective when surgical and systemic complication risks are properly evaluated using ASA-PS and GA.

Conclusions:

• Elderly patients with STS can achieve outcomes similar to younger patients with standard treatment, provided appropriate risk stratification.
• Geriatric assessment and ASA-PS are crucial for optimizing treatment decisions and minimizing complications in older adults with STS.
• Future clinical trials should include broader eligibility criteria to better represent the growing elderly population with STS.